Filing Details
- Accession Number:
- 0001439222-21-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-16 16:14:21
- Reporting Period:
- 2021-03-01
- Accepted Time:
- 2021-03-16 16:14:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1439222 | Agios Pharmaceuticals Inc. | AGIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1840076 | Darrin Miles | C/O Agios Pharmaceuticals Inc. 88 Sidney Street Cambridge MA 02139 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-03-01 | 2,200 | $47.99 | 11,171 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-05 | 500 | $48.58 | 10,671 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Includes 314 shares purchased through the Company's employee stock purchase plan.